Rehabilitation with the Shoulder Pacemaker
Launched by UNIVERSITY OF UTAH · Jul 8, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The reverse shoulder arthroplasty (RSA) has increased utility in recent years for shoulder conditions such as rotator cuff tear arthropathy, massive irreparable rotator cuff tears, severe glenohumeral arthritis, proximal humerus fracture, and failed shoulder arthroplasty. While RSA may commonly be the only surgical treatment for some of these conditions, the outcomes and adverse event profiles are significant. Specifically, RSA patients often complain of poor range of motion and function with the arm above the head. Despite many attempts at solving these shortcomings with new implant design...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients indicated for primary reverse shoulder arthroplasty
- • Surgery at University of Utah Facilities
- • Patients between the ages 18-80.
- Exclusion Criteria:
- • Prior ipsilateral shoulder arthroplasty
- • Inability or unwillingness to participate in the rehabilitation protocol
- • Prior cardiac pacemaker or spinal cord stimulator
- • Age over 80
- • History of periscapular surgery
- • History of ipsilateral neurologic injury
- • Prisoners
- • Patients requiring prolonged immobilization deviating from standard protocol
- • Patients who have an implantable medical device or other electrical device.
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Patients applied
Trial Officials
Christopher Joyce, M.D.
Principal Investigator
University of Utah Orthopaedics
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported